Opus Genetics is trading at $3.86, 5.46% up on August 11, 2026, but the catalyst remains unclear.

  • No new company announcement dated August 11 was identified; the latest official release was August 6.
  • Recent updates include $88.8 million in cash, an expected runway into 2029, and upcoming clinical milestones.
  • The company has not explicitly linked those developments to today’s move.